CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer

Cancer Medicine
Xiao-Guang ZhangFang-Min Chen

Abstract

CD164 was found to play a role in many malignant diseases. But the roles of CD164 in human bladder cancer have not yet been studied. The object of our study was to investigate the functions of CD164 in urothelial bladder carcinoma. The immunohistochemistry (IHC) was performed to evaluate the associations between the expression level of CD164 and clinical-pathological features of patients, and IHC was used to analyze the relationship between CD164 and CXCR4 in tumor tissues. Real-time qPCR and Western blot were used to measure the expression of relevant genes. The roles of CD164 in tumor cells and tissues were investigated by in vitro and in vivo experiments. The results of immunohistochemistry found that CD164 was associated with clinical and pathological features of patients. High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients. In vitro, by silencing of CD164, the proliferation, migration, and invasion of tumor cells were inhibited significantly by regulating related proteins such as Ki67, proliferating cell nuclear antigen, matrix metalloproteinases-2, and matrix metalloproteinases-9. In vivo, knocking-down of CD164 could reduce the growth and metastasis of tumors in mice...Continue Reading

References

Sep 22, 1999·European Journal of Biochemistry·N KurosawaT Muramatsu
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R DoyonnasS M Watt
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Yasuhiro TadaSeiji Naito
Jan 30, 2008·The Journal of Biological Chemistry·Gyu-Un BaeRobert S Krauss
Jun 5, 2010·Annals of the Royal College of Surgeons of England·Richard T BryanGraham M Sole
Jun 23, 2010·CA: a Cancer Journal for Clinicians·Bruce L JacobsJames E Montie
Oct 23, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daisuke UchidaYouji Miyamoto
Jun 25, 2013·The Journal of Investigative Dermatology·Maria WysockaAlain H Rook
Apr 24, 2014·International Journal of Molecular Medicine·Jia-Ang ShiWei Tan
Jun 13, 2014·International Journal of Cancer. Journal International Du Cancer·Colleen WebberPatti A Groome
Apr 3, 2015·World Journal of Urology·Soum D LokeshwarMark S Soloway
Nov 3, 2015·Acta Dermato-venereologica·Emmanuella GuenovaAntonio Cozzio
Apr 7, 2016·Biochemical and Biophysical Research Communications·Wenjun JiangDali Tian
Jun 22, 2016·European Urology·Marko BabjukRichard Zigeuner
Jun 28, 2016·Lancet·Ashish M KamatWassim Kassouf
Mar 2, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Nina Lykkegaard AndersenMogens Vyberg
Mar 6, 2017·Molecular Medicine Reports·Ming TuSongtao Qi
Nov 9, 2017·Nature·Michelle Grayson
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.